Previously, we reported a new Vitamin D gene therapy to treat AML mice by overexpressing the CYP27B1 ectopic gene, which encodes the 1-alpha-hydroxylase to generate active Vitamin D in situ[21]. The gene discussed is CYP27B1; the disease is acute myeloid leukemia.